AM Pappas Family Partnership

About

Providing Leadership for a World of Innovation. - Pappas Capital Aktis Oncology Reports First-in-Human Clinical Imaging… BOSTON, May 21, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including... Read More Investor Login Providing Leadership for a World of Innovation. At Pappas Capital, we are dedicated to furthering life science discoveries and bringing groundbreaking solutions to market. x 05.21.2026 BOSTON, May 21, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis ... Read More For 32 years Pappas Capital has been investing in and building innovative companies that are developing the next generation of life science products and technologies. We’ve invested in more than 100 companies across the United States, Canada and Asia – in fields that span the range of human disease. The products our companies have brought to market – for treating such conditions as melanoma, ovarian cancer, and hemophilia, to name a few – have been used throughout the world to treat tens of thousands of patients and account for billions of dollars of revenue. Whether you’re looking for capital or have capital to invest, contact us and learn how we can put our expertise to work for you. Portfolio Companies Pioneering the next generation of advancement in life sciences. View Portfolio An Expert Team Dedicated to Success. An experienced team of in

Key Contact

Geographic Focus